.jpg)
![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Visen Pharmaceuticals, a biotech developing much of Ascendis Pharma’s endocrine-...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
Plus, news about Century Therapeutics, Akebia Therapeutics, Eyenovia, Betaliq, A...
UnitedHealth Group's pharmacy benefit manager Optum Rx is making changes to its ...
SAN DIEGO — At the headquarters of Illumina last week, CEO Jacob Thaysen bounded...
Monte Rosa Therapeutics reported Phase 1 data Thursday morning for a Novartis-pa...
Paratek Pharmaceuticals is expanding beyond antibiotics and infectious disease b...
Sanofi is buying a B cell-depleting antibody developed by Dren Bio as a therapy ...
Sanofi is buying a B cell-depleting antibody developed by Dren Bio as a therapy ...
Sanofi is buying a B cell-depleting antibody developed by Dren Bio as a therapy ...
For cardiologist Haritha Alla, a typical day in her Los Angeles-area clinic is r...
Novartis released two Phase 3 datasets on Wednesday that show a new version of i...
Gilead Sciences' stock {$GILD} dropped by more than 3% on Wednesday afternoon am...
Black Diamond Therapeutics has found a buyer for an early-stage targeted cancer ...
President Donald Trump's new administration defended Biden-era restrictions on t...
Immunovant will not seek approval for its candidate for the autoimmune disorder ...